Literature DB >> 31628117

Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease.

Ke Wang1,2, Leila R Zelnick3,2, Yan Chen2,4, Andrew N Hoofnagle2,5, Terry Watnick6, Stephen Seliger6, Bryan Kestenbaum3,2.   

Abstract

BACKGROUND AND OBJECTIVES: In autosomal dominant polycystic kidney disease (ADPKD), the GFR often remains normal despite significant nephron loss. Proximal tubular secretory clearance may be reduced in ADPKD before detectable changes in GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used targeted mass spectrometry to quantify secretory solutes from blood and urine samples from 31 patients with ADPKD and preserved GFR (mean eGFR =111±11 ml/min per 1.73 m2) and 25 healthy control individuals as well as from 95 patients with ADPKD and reduced GFR (mean eGFR =53±21 ml/min per 1.73 m2) and 92 individuals with non-ADPKD CKD. We used linear regression to compare the fractional excretion of each solute between ADPKD and control groups. Among 112 patients with ADPKD, we used linear regression to determine associations of solute fractional excretion with height-adjusted total kidney volume.
RESULTS: After adjusting for demographics, clinical characteristics, and kidney function measures, the fractional excretions of three secretory solutes were lower in patients with ADPKD and preserved GFR compared with healthy individuals: 52% lower cinnamoylglycine excretion (95% confidence interval, 24% to 70%), 53% lower tiglylglycine excretion (95% confidence interval, 23% to 71%), and 91% lower xanthosine excretion (95% confidence interval, 83% to 95%). In addition to lower excretions of tiglylglycine and xanthosine, patients with ADPKD and reduced GFR also demonstrated 37% lower dimethyluric acid excretion (95% confidence interval, 21% to 50%), 58% lower hippurate excretion (95% confidence interval, 48% to 66%), 48% lower isovalerylglycine excretion (95% confidence interval, 37% to 56%), and 31% lower pyridoxic acid excretion (95% confidence interval, 16% to 42%) compared with patients with non-ADPKD CKD and comparable eGFR. Among patients with ADPKD, solute fractional excretions were not associated with differences in kidney volume.
CONCLUSIONS: Patients with ADPKD and preserved and reduced GFR demonstrate lower tubular secretory solute excretion compared with healthy controls and patients with non-ADPKD CKD. Our results suggest that tubular secretion is impaired in ADPKD independent of GFR.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  Proximal tubular secretion; Tubular solute clearance; chronic renal insufficiency; cinnamoylglycine; control groups; demography; glomerular filtration rate; glycine; hippurates; humans; kidney; linear models; mass spectrometry; nephrons; polycystic kidney disease; polycystic kidney, autosomal dominant; pyridoxic acid; ribonucleosides; tiglyglycine; xanthosine

Mesh:

Substances:

Year:  2019        PMID: 31628117      PMCID: PMC6946073          DOI: 10.2215/CJN.05610519

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  42 in total

1.  THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

Authors:  H W Smith; N Finkelstein; L Aliminosa; B Crawford; M Graber
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

2.  Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

Authors:  Joachim H Ix; Christina L Wassel; Lesley A Stevens; Gerald J Beck; Marc Froissart; Gerjan Navis; Roger Rodby; Vicente E Torres; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

Review 3.  What do drug transporters really do?

Authors:  Sanjay K Nigam
Journal:  Nat Rev Drug Discov       Date:  2014-12-05       Impact factor: 84.694

4.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).

Authors:  William R Wikoff; Megha A Nagle; Valentina L Kouznetsova; Igor F Tsigelny; Sanjay K Nigam
Journal:  J Proteome Res       Date:  2011-04-22       Impact factor: 4.466

5.  A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease.

Authors:  Sandra L Taylor; Sheila Ganti; Nikolay O Bukanov; Arlene Chapman; Oliver Fiehn; Michael Osier; Kyoungmi Kim; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-03

6.  Tubular Secretion in CKD.

Authors:  Astrid M Suchy-Dicey; Thomas Laha; Andrew Hoofnagle; Rick Newitt; Tammy L Sirich; Timothy W Meyer; Ken E Thummel; N David Yanez; Jonathan Himmelfarb; Noel S Weiss; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

7.  Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.

Authors:  W D Kaehny; D J Tangel; A M Johnson; W J Kimberling; R W Schrier; P A Gabow
Journal:  Am J Med       Date:  1990-07       Impact factor: 4.965

8.  Renal ammonia in autosomal dominant polycystic kidney disease.

Authors:  V E Torres; D S Keith; K P Offord; S P Kon; D M Wilson
Journal:  Kidney Int       Date:  1994-06       Impact factor: 10.612

9.  Hyperuricemia, gout, and autosomal dominant polycystic kidney disease.

Authors:  E Mejías; J Navas; R Lluberes; M Martínez-Maldonado
Journal:  Am J Med Sci       Date:  1989-03       Impact factor: 2.378

10.  Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease.

Authors:  Eun Young Park; Bo Hye Kim; Eun Ji Lee; EunSun Chang; Dae Won Kim; Soo Young Choi; Jong Hoon Park
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

View more
  5 in total

1.  Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate.

Authors:  Yan Chen; Leila R Zelnick; Andrew N Hoofnagle; Catherine K Yeung; Laura M Shireman; Brian Phillips; Calder C Brauchla; Ian de Boer; Linda Manahan; Susan R Heckbert; Jonathan Himmelfarb; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2020-11-25       Impact factor: 10.121

2.  Kidney Tubulointerstitial Fibrosis and Tubular Secretion.

Authors:  Pranav S Garimella; Ronit Katz; Sushrut S Waikar; Anand Srivastava; Insa Schmidt; Andrew Hoofnagle; Ragnar Palsson; Helmut G Rennke; Isaac E Stillman; Ke Wang; Bryan R Kestenbaum; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2021-09-24       Impact factor: 11.072

3.  Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Yan Chen; Leila R Zelnick; Matthew P Huber; Ke Wang; Nisha Bansal; Andrew N Hoofnagle; Rajan K Paranji; Susan R Heckbert; Noel S Weiss; Alan S Go; Chi-Yuan Hsu; Harold I Feldman; Sushrut S Waikar; Rupal C Mehta; Anand Srivastava; Stephen L Seliger; James P Lash; Anna C Porter; Dominic S Raj; Bryan R Kestenbaum
Journal:  Am J Kidney Dis       Date:  2021-01-07       Impact factor: 11.072

4.  Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease.

Authors:  Madhurima M Baliga; Jost Klawitter; Uwe Christians; Katharina Hopp; Michel Chonchol; Berenice Y Gitomer; Melissa A Cadnapaphornchai; Jelena Klawitter
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

5.  Assessment of kidney proximal tubular secretion in critical illness.

Authors:  Pavan K Bhatraju; Xin-Ya Chai; Neha A Sathe; John Ruzinski; Edward D Siew; Jonathan Himmelfarb; Andrew N Hoofnagle; Mark M Wurfel; Bryan R Kestenbaum
Journal:  JCI Insight       Date:  2021-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.